Doctoral Bridge Program

The Doctoral Bridge Program is a combined M.S.-Ph.D. program. It is designed for undergraduate and new master’s students who wish to pursue a Ph.D. without delay. Although the Bridge program does not necessarily reduce the amount of time it take to complete the two degrees, it allows students to begin their research training earlier than traditional doctoral programs.

The first year of study is similar to the other master’s students’ courses. Bridge students are encouraged to participate in research activities early on and should complete a master’s thesis by the end of the second year (This is a requirement for Bridge students who receive funding.). In the fall semester of the second year of the master’s program, Bridge students are assigned a masters/doctoral TDP committee and begin to participate in doctoral courses and activities (as well as continue with the master’s programming).

This program is tailor-made to each student and does not compromise the requirements for either the master’s or the doctoral degree. Most bridge students complete both the clinical Master’s degree (to become a licensed speech-language pathologist) and the Ph.D. (doctoral) degree.  Students not pursuing a clinical credential may elect to complete only the doctoral degree within this program. However, students not pursuing the clinical masters should be aware that if they leave the program without completing the doctorate, BGSU does not offer a non-clinical master’s degree.   

The typical interval to complete the Bridge program (earning both the master’s and doctoral degrees) is 6 years. The duration of the program may be longer for students who desire to become complete their Clinical Fellowship Year during the program.

If you are interested in the Bridge program, please read over the web pages for the master’s program and doctoral program. These will give you more information that is helpful for Bridge students. 

Inquiries about the doctoral bridge program should be directed to the graduate coordinator, Dr. Kim Traver.